Kymera Therapeutics, Inc. · NASDAQ:KYMR

T. Rowe Price Associates Inc reported a 7.10% stake in Kymera Therapeutics, Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

T. Rowe Price Associates Inc reported a 7.10% stake in Kymera Therapeutics, Inc., 5,097,704 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
7.10%
Shares
5,097,704
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
T. Rowe Price Associates, Inc.7.10%5,097,704

Source

View original at SEC

Related